How gut bacteria from women with eating disorders affect digestion and behavior
Official title: Effects of Fecal Microbiota Transplantation From Patients With Eating Disorders on Body Weight Development in Mice
Run by University Hospital, Rouen · NCT07196189 · Data updated 2026-11-12
This project will test whether gut bacteria taken from women with anorexia, bulimia, or binge-eating cause changes in digestion and eating-related behavior when transplanted into mice, compared with bacteria from healthy women.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 50 Years |
| Sex | All |
| Enrollment | 84 (estimated) |
| Sponsor | University Hospital, Rouen Academic / other |
| Locations | 1 site (Rouen) |
| Status | Recruiting |
| Started | March 16, 2022 |
| Main results expected | November 16, 2026 |
| Study ends | April 16, 2027 |
| Registry record updated | September 29, 2025 |
| Trial ID | NCT07196189 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Women aged 18 to 50 who are presenting for a first consultation for anorexia nervosa, bulimia nervosa, or binge-eating disorder at Rouen University Hospital and who screen positive on the SCOFF questionnaire are ideal candidates.
✕Probably not a fit
Participants should not expect direct clinical benefit from participation because the protocol involves donating stool for mouse experiments rather than receiving a therapeutic intervention, and people with recent antibiotics, IBD, or prior gut surgery are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will collect stool samples from women aged 18–50 who present with anorexia nervosa, bulimia nervosa, or binge-eating disorder at Rouen University Hospital, and from matched healthy female volunteers. Fecal microbiota from these donors will be transferred into mice to see whether recipient animals develop changes in intestinal physiology, digestion, or behaviors related to eating. Results from mice receiving microbiota from patients will be compared with those receiving microbiota from healthy donors to test for a causal role of dysbiosis. The work aims to clarify microbiota-driven mechanisms that could underlie or perpetuate eating disorder symptoms and related digestive problems.
Why it matters
Potential benefit: If successful, the findings could point to new microbiome-based strategies to improve digestive symptoms and complement treatments for eating disorders.
How similar studies have gone: Previous mouse transfer experiments have linked gut microbiota to weight and behavior changes and suggest a plausible role in eating-related behaviors, but human therapeutic evidence remains limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients with ED * Women. * Aged 18 to 50. * First consultation in the Nutrition Department of Rouen University Hospital for ED. * Positive SCOFF with diagnosis of anorexia nervosa, bulimia nervosa, or binge eating disorder. * Affiliation with a social security plan. * Patient who has read and understood the information letter and does not object to participating in the study. Healthy Volunteers * Women. * Aged 18 to 50. * Body mass index between 18.5 and 24.9 kg/m². * SCOFF test: no positive response. * No history of ED or active ED (DSM V criteria negative). * Affiliation with a social security plan. * Individual who has read and understood the information letter and does not object to participating in the study. Exclusion Criteria: Patients with ED * Men. * Aged under 18 and over 50. * Negative SCOFF. * Patients who have received antibiotic treatment in the last 3 months. * Patients with a history of IBD or surgical procedures on the digestive tract. * Patient refuses to participate in the study. * Persons deprived of liberty by judicial or administrative order. * Pregnant or breastfeeding women. * Protected persons (guardianship or curatorship). Healthy volunteers * Men. * Aged under 18 and over 50. * SCOFF test with at least one positive response. * History or active ED (DSM V criteria). * Persons who have received antibiotic treatment in the last 3 months. * Person with a history of IBD or surgical procedures on the digestive tract. * Body mass index less than 18.5 or greater than 24.9 kg/m2. * Pregnant or breastfeeding women. * Protected persons (guardianship or curatorship).
Where it's running
-
University Rouen Hospital
Rouen, France Recruiting
Study contacts
- Study coordinator: Pierre PD DECHELOTTE, Professor
- Email: Pierre.Dechelotte@chu-rouen.fr
- Phone: 02 32 88 64 65
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oral signs to help spot eating disorders early
This project will test whether a standardized checklist of mouth and dental signs can help detect eating disorders in adults aged 18–40 during routine dental visits.
-
See if preoperative anxiety affects recovery after major digestive cancer surgery
This study tests whether anxiety before surgery is linked to more complications after major digestive cancer operations in French-speaking adults.
-
Using EEG to monitor sleep quality in ICU patients with respiratory failure
We will test whether continuous EEG monitoring can better track sleep quality than nurse observations in conscious adults hospitalized in the ICU for acute respiratory failure.
-
Gynecological and sexual aftereffects following rectal cancer treatment
This work will test whether gynecological anatomical changes after rectal cancer treatment are linked to ongoing sexual problems in women aged 18–60 who are in remission.
-
Long-read genetic analysis for Spinal Muscular Atrophy (LOREASI)
This project tries a long-read DNA technique on adults with known SMN1 copy-number patterns to find hidden '2+0' carrier genotypes that standard tests miss.
-
Carotid artery wall viscosity and memory problems in older adults
This project will test whether the viscous behavior of the carotid artery wall is linked to memory problems in people over 70 with memory complaints, Alzheimer's disease, or vascular dementia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.